Strydom A - Search Results

1

Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.

Mengel D, Liu W, Glynn RJ, Selkoe DJ, Strydom A, Lai F, Rosas HD, Torres A, Patsiogiannis V, Skotko B, Walsh DM. Mengel D, et al. Among authors: strydom a. Alzheimers Res Ther. 2020 Mar 19;12(1):27. doi: 10.1186/s13195-020-00593-7. Alzheimers Res Ther. 2020. PMID: 32192521 Free PMC article.

2

Cognitive decline and dementia in Down syndrome.

Hithersay R, Hamburg S, Knight B, Strydom A. Hithersay R, et al. Among authors: strydom a. Curr Opin Psychiatry. 2017 Mar;30(2):102-107. doi: 10.1097/YCO.0000000000000307. Curr Opin Psychiatry. 2017. PMID: 28009725 Free article. Review.

3

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.

Zis P, Strydom A. Zis P, et al. Among authors: strydom a. Free Radic Biol Med. 2018 Jan;114:3-9. doi: 10.1016/j.freeradbiomed.2017.08.024. Epub 2017 Sep 1. Free Radic Biol Med. 2018. PMID: 28870521 Free PMC article. Review.

4

Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.

Sinai A, Mokrysz C, Bernal J, Bohnen I, Bonell S, Courtenay K, Dodd K, Gazizova D, Hassiotis A, Hillier R, McBrien J, McCarthy J, Mukherji K, Naeem A, Perez-Achiaga N, Rantell K, Sharma V, Thomas D, Walker Z, Whitham S, Strydom A. Sinai A, et al. Among authors: strydom a. J Alzheimers Dis. 2018;61(2):717-728. doi: 10.3233/JAD-170624. J Alzheimers Dis. 2018. PMID: 29226868 Free PMC article.

5

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.

Strydom A, Heslegrave A, Startin CM, Mok KY, Hardy J, Groet J, Nizetic D, Zetterberg H; LonDownS Consortium. Strydom A, et al. Alzheimers Res Ther. 2018 Apr 10;10(1):39. doi: 10.1186/s13195-018-0367-x. Alzheimers Res Ther. 2018. PMID: 29631614 Free PMC article.

6

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.

Startin CM, Hamburg S, Hithersay R, Al-Janabi T, Mok KY, Hardy J; LonDownS Consortium; Strydom A. Startin CM, et al. Among authors: strydom a. Alzheimers Dement. 2019 Feb;15(2):245-257. doi: 10.1016/j.jalz.2018.08.009. Epub 2018 Nov 28. Alzheimers Dement. 2019. PMID: 30503169 Free PMC article.

7

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.

Startin CM, Ashton NJ, Hamburg S, Hithersay R, Wiseman FK, Mok KY, Hardy J, Lleó A, Lovestone S, Parnetti L, Zetterberg H, Hye A; LonDownS Consortium; Strydom A. Startin CM, et al. Among authors: strydom a. Alzheimers Res Ther. 2019 Mar 21;11(1):26. doi: 10.1186/s13195-019-0477-0. Alzheimers Res Ther. 2019. PMID: 30902060 Free PMC article.

8

Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta-analyses.

Alhajraf F, Ness D, Hye A, Strydom A. Alhajraf F, et al. Among authors: strydom a. Dev Neurobiol. 2019 Jul;79(7):684-698. doi: 10.1002/dneu.22715. Epub 2019 Sep 11. Dev Neurobiol. 2019. PMID: 31389176 Free PMC article.

9

Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management".

Startin CM, Hamburg S, Hithersay R, Al-Janabi T, Mok KY, Hardy J, Strydom A. Startin CM, et al. Among authors: strydom a. Alzheimers Dement. 2019 Sep;15(9):1238-1239. doi: 10.1016/j.jalz.2019.05.003. Epub 2019 Aug 23. Alzheimers Dement. 2019. PMID: 31451423 No abstract available.

10

Down syndrome.

Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH. Antonarakis SE, et al. Among authors: strydom a. Nat Rev Dis Primers. 2020 Feb 6;6(1):9. doi: 10.1038/s41572-019-0143-7. Nat Rev Dis Primers. 2020. PMID: 32029743 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page